SCHEMBL6388595

SCHEMBL6388595

CCn1c(=O)[nH]c(=O)c2cccc(S(=O)(=O)O)c21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.42
▸ HDAC6 Q9UBN7 3/20 0.39
▸ HDAC8 Q9BY41 2/20 0.39
▸ HDAC3 O15379 1/20 0.39
▸ HDAC4 P56524 1/20 0.39
▸ HDAC1 Q13547 1/20 0.39
▸ HDAC7 Q8WUI4 1/20 0.39
▸ HDAC2 Q92769 1/20 0.39
▸ HDAC11 Q96DB2 1/20 0.39
▸ HDAC9 Q9UKV0 1/20 0.39
▸ HDAC5 Q9UQL6 1/20 0.39
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.38
▸ PGR P06401 1/20 0.38
▸ MAPT P10636 3/20 0.36
▸ POLB P06746 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ MPI P34949 1/20 0.36
▸ HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6394628 0.89 ADORA2A (0.44) HDAC6HDAC8HDAC3HDAC4HDAC1
SCHEMBL6389576 0.87 CNR1 (0.42) KMT2AMEN1MAPTPOLBALDH1A1
SCHEMBL6389536 0.85 SMN1; SMN2 (0.40) CYP1A2HDAC6HDAC8HDAC3HDAC4
SCHEMBL6395773 0.81 ADORA2B (0.41) CYP1A2KMT2AMEN1TTRFEN1
SCHEMBL6392722 0.79 TTR (0.37) CYP1A2HDAC6HDAC8HDAC3HDAC4
SCHEMBL6386893 0.78 KMT2A (0.48) CYP1A2HDAC6HDAC8HDAC1KMT2A
SCHEMBL6388632 0.78 CYP1A2 (0.52) CYP1A2FEN1
SCHEMBL6390848 0.78 POLB (0.38) CYP1A2PGRPOLBALDH1A1HTT
SCHEMBL6388310 0.75 MAT2A (0.41) KMT2AMEN1MAPTPOLBKDM4E
SCHEMBL6388376 0.72 CYP1A2 (0.52) CYP1A2KMT2AMEN1PGRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1237119-C Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2006-01-18 — — CN disclosed
US-20050040373-A1 Dopant and conductive polymer material therewith MITSUI CHEMICALS, INC. (JP) 2005-02-24 — — US disclosed
US-6814888-B2 FOR PRODUCING SOLID ELECTROLYTIC CAPACITOR MITSUI CHEMICALS, INC. (JP) 2004-11-09 — — US disclosed
CN-1462299-A Dopant agent and electroconductive polymer materials comprising the same MITSUI CHEMICALS INC (JP) 2003-12-17 — — CN disclosed
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same MITSUI CHEMICALS, INC. (JP) 2003-07-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030142462-A1 Dopant agent and electroconductive polymer material comprising the same RPS6, H1-10, H1-0 CYP1A2 3819/4885HDAC6 3459/4885HDAC8 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback